@RayG It's safe to say Zilosul has been significantly derisked since the first patient was injected for EAP in February 2020.
Logically I can't see how this doesn't get above its previous levels - some dilution with $35m cap raise to consider as part of the equation here but seems like this could head back to $4+ in the ST..
Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-34
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $103.1M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.5¢ | 27.5¢ | $167.1K | 590.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24553 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 49999 | 1 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |